Development and Validation Of Highly Sensitive Mrdx BCR-ABL Test For Monitoring Deep Molecular Response In Patients With Chronic Myeloid Leukemia

Julie Toplin, Chad Galderisi, Jonathan Eibl et al.|Blood|2013

Cited by 2